Nausea affects up to 44% of patients on GLP-1 RA therapy. Learn the neuroscience behind it and 10 evidence-based strategies to reduce discomfort without stopping your medication.
分類彙整: Weight Management & GLP-1 Medications
Dealing with Vomiting and Diarrhea on GLP-1 RA: When to Push Through and When to Call Your Doctor
Vomiting and diarrhea affect 20–30% of GLP-1 RA users. Learn which symptoms are expected, which require medical attention, and how to manage hydration and electrolytes safely.
Constipation on GLP-1 RA Therapy: Causes, Dietary Fixes, and Safe Relief Options
Constipation affects up to 24% of GLP-1 RA users due to slowed gut motility. Discover evidence-based dietary strategies and safe laxative options to restore normal bowel function.
Understanding Appetite Suppression on GLP-1 RA: How Reducing ‘Food Noise’ Transforms Weight Loss
GLP-1 RAs suppress appetite through multiple brain pathways, including silencing ‘food noise.’ Learn how this mechanism drives weight loss and how to optimize your eating patterns.
Gastroparesis and Delayed Gastric Emptying: The GLP-1 RA Side Effect You Need to Know About
GLP-1 RAs delay gastric emptying, which in rare cases can progress to clinically significant gastroparesis. Learn the warning signs, anesthesia implications, and when to seek care.
Pancreatitis Risk with GLP-1 RA: Recognizing Warning Signs and When to Seek Emergency Care
Pancreatitis is a rare but serious GLP-1 RA side effect affecting less than 1% of users. Know the classic warning signs and understand when to seek immediate emergency medical care.
Gallstones and Gallbladder Disease: Why Rapid Weight Loss on GLP-1 RA Increases Your Risk
Rapid weight loss on GLP-1 RA therapy increases gallstone risk by 2-3% above placebo. Learn the mechanism, warning signs, and how to protect your gallbladder during weight loss.
Drug Interactions with GLP-1 RA Medications: Oral Contraceptives, Thyroid Drugs, and Diabetes Medications
GLP-1 RA medications slow gastric emptying and can alter absorption of oral drugs. Learn about clinically significant interactions with contraceptives, thyroid medications, diabetes drugs, and more.
Absolute and Relative Contraindications for GLP-1 RA: Who Should Not Use These Medications
A comprehensive clinical review of absolute and relative contraindications for GLP-1 RA medications—including MTC, MEN2, pregnancy, severe GI disease, and pancreatitis history.
The Dangers of Compounded Semaglutide and Tirzepatide: FDA Warnings, Quality Risks, and What Patients Must Know
FDA-approved GLP-1 RA medications have safe, verified formulations. Compounded versions carry serious risks including dosing errors, contamination, and unverified ingredients—here’s what you must know.